Caryn Libbey

3.1k total citations
10 papers, 994 citations indexed

About

Caryn Libbey is a scholar working on Molecular Biology, Surgery and Nephrology. According to data from OpenAlex, Caryn Libbey has authored 10 papers receiving a total of 994 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 3 papers in Surgery and 3 papers in Nephrology. Recurrent topics in Caryn Libbey's work include Amyloidosis: Diagnosis, Treatment, Outcomes (9 papers), Pancreatitis Pathology and Treatment (3 papers) and Protein Kinase Regulation and GTPase Signaling (2 papers). Caryn Libbey is often cited by papers focused on Amyloidosis: Diagnosis, Treatment, Outcomes (9 papers), Pancreatitis Pathology and Treatment (3 papers) and Protein Kinase Regulation and GTPase Signaling (2 papers). Caryn Libbey collaborates with scholars based in United States. Caryn Libbey's co-authors include Jennifer J. Anderson, Rodney H. Falk, Alan S. Cohen, Martha Skinner, Lee Anna Jones, Robert W. Simms, Carl O’Hara, John L. Berk, David C. Seldin and Laura M. Dember and has published in prestigious journals such as New England Journal of Medicine, Annals of Internal Medicine and The American Journal of Medicine.

In The Last Decade

Caryn Libbey

10 papers receiving 957 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Caryn Libbey United States 8 923 252 229 211 181 10 994
Kyle Ra United States 6 872 0.9× 250 1.0× 198 0.9× 172 0.8× 118 0.7× 8 971
Hugh J. B. Goodman United Kingdom 12 666 0.7× 158 0.6× 183 0.8× 158 0.7× 120 0.7× 22 758
Ray Comenzo United States 6 1.1k 1.2× 366 1.5× 287 1.3× 216 1.0× 175 1.0× 17 1.1k
Kathleen T. Finn United States 11 1.2k 1.3× 245 1.0× 485 2.1× 309 1.5× 204 1.1× 28 1.3k
Prayman Sattianayagam United Kingdom 13 968 1.0× 384 1.5× 117 0.5× 164 0.8× 181 1.0× 27 1.1k
David Lavergne France 9 514 0.6× 200 0.8× 117 0.5× 84 0.4× 69 0.4× 18 581
Isabelle Lousada United States 9 804 0.9× 335 1.3× 100 0.4× 119 0.6× 156 0.9× 25 864
David F. Hutt United Kingdom 13 1.1k 1.2× 575 2.3× 75 0.3× 95 0.5× 205 1.1× 29 1.3k
Christian Gagliardi Italy 13 1.3k 1.4× 675 2.7× 66 0.3× 121 0.6× 239 1.3× 33 1.4k
John P. Garton United States 10 224 0.2× 59 0.2× 205 0.9× 71 0.3× 55 0.3× 11 570

Countries citing papers authored by Caryn Libbey

Since Specialization
Citations

This map shows the geographic impact of Caryn Libbey's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Caryn Libbey with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Caryn Libbey more than expected).

Fields of papers citing papers by Caryn Libbey

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Caryn Libbey. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Caryn Libbey. The network helps show where Caryn Libbey may publish in the future.

Co-authorship network of co-authors of Caryn Libbey

This figure shows the co-authorship network connecting the top 25 collaborators of Caryn Libbey. A scholar is included among the top collaborators of Caryn Libbey based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Caryn Libbey. Caryn Libbey is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Beaudette-Zlatanova, Britte, Robert Lew, John D. Otis, et al.. (2023). Pilot Study of Low-dose Naltrexone for the Treatment of Chronic Pain Due to Arthritis: A Randomized, Double-blind, Placebo-controlled, Crossover Clinical Trial. Clinical Therapeutics. 45(5). 468–477. 5 indexed citations
2.
Skinner, Martha, Vaishali Sanchorawala, David C. Seldin, et al.. (2004). High-Dose Melphalan and Autologous Stem-Cell Transplantation in Patients with AL Amyloidosis: An 8-Year Study. Annals of Internal Medicine. 140(2). 85–93. 427 indexed citations
3.
Anderson, Jennifer J., Robert W. Simms, Rodney H. Falk, et al.. (1996). Treatment of 100 patients with primary amyloidosis: A randomized trial of melphalan, prednisone, and colchicine versus colchicine only. The American Journal of Medicine. 100(3). 290–298. 266 indexed citations
4.
Cabot, Richard C., Robert E. Scully, Eugene J. Mark, et al.. (1987). Case 50-1987. New England Journal of Medicine. 317(24). 1520–1531. 7 indexed citations
5.
Cohen, Alan S., Alan Rubinow, Jennifer J. Anderson, et al.. (1987). Survival of patients with primary (AL) amyloidosis. The American Journal of Medicine. 82(6). 1182–1190. 73 indexed citations
6.
Skinner, Martha, Lawreen H. Connors, Alan Rubinow, et al.. (1985). Lowered Prealbumin Levels in Patients with Familial Amyloid Polyneuropathy (FAP) and Their Non-Affected But At Risk Relatives. The American Journal of the Medical Sciences. 289(1). 17–21. 29 indexed citations
7.
Libbey, Caryn, Alan Rubinow, Tsuranobu Shirahama, Chad Deal, & Alan S. Cohen. (1984). Familial amyloid polyneuropathy. The American Journal of Medicine. 76(1). 18–24. 22 indexed citations
8.
Libbey, Caryn. (1983). Use of abdominal fat tissue aspirate in the diagnosis of systemic amyloidosis. Archives of Internal Medicine. 143(8). 1549–1552. 21 indexed citations
9.
Libbey, Caryn. (1983). Use of Abdominal Fat Tissue Aspirate in the Diagnosis of Systemic Amyloidosis. Archives of Internal Medicine. 143(8). 1549–1549. 139 indexed citations
10.
As, Cohen, et al.. (1983). Juvenile rheumatoid arthritis with renal amyloidosis: a 23-year survival.. PubMed. 9(6). 921–5. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026